信息披露違規 瑞普生物(300119.SZ)及相關人員被警示
格隆匯 12 月 25日丨瑞普生物(300119.SZ)公佈,公司於2020年12月25日收到中國證券監督管理委員會天津監管局(“天津證監局”)下發的《關於對天津瑞普生物技術股份有限公司釆取出具警示函措施的決定》(津證監措施〔2020〕27號,“警示函一”)、《關於對李守軍釆取出具警示函措施的決定》(津證監措施〔2020〕28號,“警示函二”)、《關於對徐雷釆取出具警示函措施的決定》(津證監措施〔2020〕29號,“警示函三”),原因系公司存在以下違規行為:
公司營銷中心以員工個人名義開設賬户收取客户款項,對其中“風險保證金”款項未納入公司賬户存儲及賬務核算。公司2019年、2020年未納入賬户存儲與賬務核算的客户“風險保證金”分別為3093.76萬元和1245.55萬元,影響了公司2019年年度報吿、2020年中期報吿資產與負債項目數據的準確性,同時影響了公司2019年度內部控制自我評價報吿的準確性。上述行為違反了《上市公司信息披露管理辦法》第二條第一款的規定。
前述違規事項發生期間,李守軍任瑞普生物董事長、總經理,且在2019年年度報吿、2020年中期報吿作為主管會計工作負責人進行聲明並簽字。其未忠實、勤勉地履行職責,對公司前述違規事項負有責任,違反了《上市公司信息披露管理辦法》第三條的規定。
前述違規事項發生期間,徐雷任瑞普生物營銷中心負責人,2019年12月25日任公司副總經理,2020年4月23日任公司董事。其未忠實、勤勉地履行職責,對公司前述違規事項負有責任,違反了《上市公司信息披露管理辦法》第三條的規定。
根據《上市公司信息披露管理辦法》第五十九條的規定,天津證監局決定對公司及相關人員採取出具警示函的行政監管措施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.